prednisolone has been researched along with Elevated Cholesterol in 22 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The therapy of nephrotic syndrome in focal segmental glomerulosclerosis (FSGS) is still a matter of controversy." | 6.71 | Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. ( Braun, N; Fünfstück, R; Grabensee, B; Heering, P; Ivens, K; Keller, F; Krämer, BK; Müllejans, R; Risler, T; Schollmeyer, P; Zäuner, I, 2004) |
| "Hypercholesterolemia was observed in 46% to 80% and hypertriglyceridemia in 43% to 78% of sirolimus-treated patients during the first 6 posttransplantation months." | 3.72 | Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis. ( Chueh, SC; Kahan, BD, 2003) |
| " Prophylaxis against graft-versus-host disease (GVHD) consisted of cyclosporine (CsA) and short-term methotrexate." | 3.72 | [Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation]. ( Koyama, M; Kunisaki, Y; Matsue, K; Matsuoka, K; Takeuchi, M, 2004) |
| " Dosing of these agents was concentration-controlled and open-labeled." | 2.71 | Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study. ( Bäckman, L; Brattström, C; Calne, R; Campistol, JM; Charpentier, B; Claesson, K; Durand, D; Groth, CG; Kreis, H; Lang, P; Morales, JM; Touraine, JL; Wramner, L, 2003) |
| "The therapy of nephrotic syndrome in focal segmental glomerulosclerosis (FSGS) is still a matter of controversy." | 2.71 | Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. ( Braun, N; Fünfstück, R; Grabensee, B; Heering, P; Ivens, K; Keller, F; Krämer, BK; Müllejans, R; Risler, T; Schollmeyer, P; Zäuner, I, 2004) |
| "Hypercholesterolemia was evident in 66." | 1.30 | Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. ( Bechstein, WO; Guckelberger, O; Jonas, S; Kratschmer, B; Lemmens, HP; Luesebrink, R; Neuhaus, PL; Neuhaus, R, 1997) |
| " Twelve potential risk factors were evaluated as covariates: recipient age, body weight after 6 months, body weight gain over 6 months, body mass index after 6 months, body mass index gain over 6 months, current cyclosporine dosage, trough level of cyclosporine in whole blood according to high-performance liquid chromatography after 6 months, cumulative cyclosporine dosage over 6 months, serum bilirubin, type of original cardiac disease, maintenance steroids, and steroid bolus treatment." | 1.28 | The determinants of elevated total plasma cholesterol levels in cardiac transplant recipients administered low dose cyclosporine for immunosuppression. ( Grablowitz, V; Heinz, G; Laczkovics, A; Laufer, G; Miholic, J; Schreiner, W; Wolfram, J; Wollenek, G; Wolner, E, 1992) |
| " This change coincided with the attainment of maintenance steroid dosage (usually prednisolone 10 mg." | 1.26 | Hyperlipidaemia following renal transplantation. A study of the prevalence, 'natural history' and dietary treatment. ( Gokal, R; Mann, JI; Moore, RA; Morris, PJ, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (27.27) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiguro, H | 1 |
| Hashimoto, T | 1 |
| Akata, M | 1 |
| Suzuki, S | 1 |
| Azushima, K | 1 |
| Kobayashi, Y | 1 |
| Kanaoka, T | 1 |
| Yoshida, S | 1 |
| Wakui, H | 1 |
| Oshikawa, J | 1 |
| Nagahama, K | 1 |
| Inayama, Y | 1 |
| Tamura, K | 1 |
| Toya, Y | 1 |
| Umemura, S | 1 |
| Lin, CF | 1 |
| Lee, KJ | 1 |
| Yu, SS | 1 |
| Lin, YS | 1 |
| Nakajima, A | 1 |
| Doki, K | 1 |
| Homma, M | 1 |
| Sagae, T | 1 |
| Saito, R | 1 |
| Ito, S | 1 |
| Sumida, T | 1 |
| Kohda, Y | 1 |
| Grosch, S | 1 |
| Van Overmeire, L | 1 |
| Krzesinski, JM | 1 |
| Bovy, C | 1 |
| Charpentier, B | 1 |
| Groth, CG | 1 |
| Bäckman, L | 1 |
| Morales, JM | 1 |
| Calne, R | 1 |
| Kreis, H | 1 |
| Lang, P | 1 |
| Touraine, JL | 1 |
| Claesson, K | 1 |
| Campistol, JM | 1 |
| Durand, D | 1 |
| Wramner, L | 1 |
| Brattström, C | 1 |
| Pannu, HS | 1 |
| Singh, D | 1 |
| Sandhu, JS | 1 |
| Chueh, SC | 1 |
| Kahan, BD | 1 |
| BONATI, B | 1 |
| RANCATI, GB | 1 |
| MANFREDI, GC | 1 |
| FERRARI, C | 1 |
| Heering, P | 1 |
| Braun, N | 1 |
| Müllejans, R | 1 |
| Ivens, K | 1 |
| Zäuner, I | 1 |
| Fünfstück, R | 1 |
| Keller, F | 1 |
| Krämer, BK | 1 |
| Schollmeyer, P | 1 |
| Risler, T | 1 |
| Grabensee, B | 1 |
| Koyama, M | 1 |
| Matsuoka, K | 1 |
| Kunisaki, Y | 1 |
| Takeuchi, M | 1 |
| Matsue, K | 1 |
| Fassbender, WJ | 1 |
| Akbas, SH | 1 |
| Yurdakonar, E | 1 |
| Yucetin, L | 1 |
| Senol, Y | 1 |
| Tuncer, M | 1 |
| Kocak, H | 1 |
| Akbas, M | 1 |
| Gurkan, A | 1 |
| Demirbas, A | 1 |
| Gultekin, M | 1 |
| Sokolovskaya, IV | 1 |
| Nikiforova, NV | 1 |
| Aakhus, S | 1 |
| Dahl, K | 1 |
| Widerøe, TE | 1 |
| Guckelberger, O | 1 |
| Bechstein, WO | 1 |
| Neuhaus, R | 1 |
| Luesebrink, R | 1 |
| Lemmens, HP | 1 |
| Kratschmer, B | 1 |
| Jonas, S | 1 |
| Neuhaus, PL | 1 |
| Tsukahara, H | 1 |
| Haruki, S | 1 |
| Hiraoka, M | 1 |
| Hori, C | 1 |
| Sudo, M | 1 |
| Gokal, R | 1 |
| Mann, JI | 1 |
| Moore, RA | 1 |
| Morris, PJ | 1 |
| Laufer, G | 1 |
| Grablowitz, V | 1 |
| Laczkovics, A | 1 |
| Miholic, J | 1 |
| Heinz, G | 1 |
| Wollenek, G | 1 |
| Schreiner, W | 1 |
| Wolfram, J | 1 |
| Wolner, E | 1 |
| Ettenger, RB | 1 |
| Rosenthal, JT | 1 |
| Marik, J | 1 |
| Grimm, PC | 1 |
| Nelson, P | 1 |
| Malekzadeh, MH | 1 |
| Fine, RN | 1 |
| Yoshimoto, K | 1 |
| Saima, S | 1 |
| Nakamura, Y | 1 |
| Ishikawa, H | 1 |
| Kinoshita, M | 1 |
| Yokohari, R | 1 |
| Shibata, S | 1 |
| Farrow, BR | 1 |
| Huxtable, CR | 1 |
| Mishikawa, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA, Versus Standard Dose Tacrolimus, ECMPA Plus Corticosteroids in Patients Undergoing Liver Transplant[NCT02123108] | Phase 4 | 59 participants (Actual) | Interventional | 2011-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT02123108)
Timeframe: 12 months post liver transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 3 |
| Tacrolimus Group | 4 |
(NCT02123108)
Timeframe: 12 months post liver transplantation
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 0 |
| Tacrolimus Group | 0 |
(NCT02123108)
Timeframe: 12 months post transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 2 |
| Tacrolimus Group | 5 |
Number of participants who experienced dialysis independence or improvement based upon kidney function labs as a measure of renal recovery/ function following OLT in patients after undergoing orthotopic liver transplant (NCT02123108)
Timeframe: 12 months post-transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 28 |
| Tacrolimus Group | 26 |
Participants at risk minus incidence of death within the first year post-transplant (NCT02123108)
Timeframe: 12 months post liver transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 28 |
| Tacrolimus Group | 26 |
2 trials available for prednisolone and Elevated Cholesterol
| Article | Year |
|---|---|
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Drug Therapy, Combination; France; Graft Reject | 2003 |
Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
Topics: Adult; Aged; Alkylating Agents; Biopsy; Chlorambucil; Cyclosporine; Drug Therapy, Combination; Femal | 2004 |
20 other studies available for prednisolone and Elevated Cholesterol
| Article | Year |
|---|---|
Rituximab treatment for adult purpura nephritis with nephrotic syndrome.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal, Murine-Derived; Anticholesteremic Agents; Cyclop | 2013 |
Effect of comorbid diabetes and hypercholesterolemia on the prognosis of idiopathic sudden sensorineural hearing loss.
Topics: Adolescent; Adult; Aged; Audiometry, Pure-Tone; Child; Comorbidity; Diabetes Complications; Female; | 2016 |
[Investigation of glucocorticoid-induced side effects in patients with autoimmune diseases].
Topics: Adult; Aged; Aged, 80 and over; Appetite; Autoimmune Diseases; Candidiasis, Oral; Dose-Response Rela | 2009 |
[Fibrillary nonamyloid glomerulonephritis: a rare etiology of nephrotic syndrome].
Topics: Coloring Agents; Complement C3; Congo Red; Diagnosis, Differential; Edema; Female; Fluorobenzenes; G | 2011 |
Lipid profile before and after renal transplantation--a longitudinal study.
Topics: Adult; Azathioprine; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cyclosporine | 2003 |
Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
Topics: Adult; Anti-Inflammatory Agents; Cardiovascular Diseases; Cohort Studies; Cyclosporine; Disease Prog | 2003 |
[Effect of prednisolone on blood and tissue levels of vitamins A, C and E in rabbits on diets inducing hypercholesterolemia].
Topics: Animals; Ascorbic Acid; Cholesterol; Diet; Hypercholesterolemia; Prednisolone; Rabbits; Vitamin A; V | 1957 |
[Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation].
Topics: Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Hyp | 2004 |
[Practical ambulatory therapy for multisystem atrophy and diabetes mellitus].
Topics: Aged; Ambulatory Care; Anti-Inflammatory Agents; Calcium; Diabetes Mellitus, Type 2; Female; Humans; | 2005 |
Relation of C-2 monitoring with serum lipid profile in stable renal transplant patients.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Environmental Monitoring; Epidemiological Monitoring | 2006 |
High-density lipoprotein cholesterol in patients with untreated and treated nephrotic syndrome.
Topics: Adolescent; Adult; Cholesterol; Cholesterol, HDL; Female; Humans; Hypercholesterolemia; Hypoproteine | 1984 |
Hyperlipidaemia in renal transplant patients.
Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Cross-Sectional Studies; Cyclosporine; Diuretics | 1996 |
Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cardiovascular Diseases; Cyclosporine; Female; Follow-Up Stu | 1997 |
Persistent hypercholesterolaemia in frequently relapsing steroid-responsive nephrotic syndrome.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cholesterol; Female; Follow-Up Studie | 1997 |
Hyperlipidaemia following renal transplantation. A study of the prevalence, 'natural history' and dietary treatment.
Topics: Adolescent; Adult; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Kidney Transp | 1979 |
The determinants of elevated total plasma cholesterol levels in cardiac transplant recipients administered low dose cyclosporine for immunosuppression.
Topics: Adult; Cholesterol; Cyclosporine; Drug Therapy, Combination; Female; Heart Transplantation; Humans; | 1992 |
Long-term results with cyclosporine immune suppression in pediatric cadaver renal transplantation.
Topics: Adolescent; Age Factors; Azathioprine; Cadaver; Child; Cyclosporins; Growth; Humans; Hypercholestero | 1991 |
[A case of acute dissecting aneurysm of the aorta in systemic lupus erythematosus].
Topics: Adult; Aortic Aneurysm; Aortic Dissection; Arteriosclerosis; Female; Humans; Hypercholesterolemia; H | 1989 |
Membranous nephropathy and the nephrotic syndrome in the cat.
Topics: Animals; Cat Diseases; Cats; Edema; Female; Hypercholesterolemia; Hypoproteinemia; Kidney; Kidney Gl | 1971 |
[Experimental studies on relation between cholesterol metabolism and endocrine function using C 14 -labelled cholesterol. 1. Effect of endocrine function on plasma cholesterol level and C 14 -labelled cholesterol metabolism in the rabbit].
Topics: Anabolic Agents; Animals; Carbon Isotopes; Cholesterol; Hypercholesterolemia; Male; Oxymetholone; Pr | 1971 |